National Cancer Institute, Egypt
Clinical trials sponsored by National Cancer Institute, Egypt, explained in plain language.
-
Maintenance gemcitabine may delay mesothelioma progression, but not extend life
Disease control CompletedThis study tested whether continuing the chemotherapy drug gemcitabine after initial treatment could help people with a rare and aggressive lung cancer called diffuse pleural mesothelioma keep their cancer from growing for a longer time. 64 patients who had already responded to f…
Phase: PHASE2 • Sponsor: National Cancer Institute, Egypt • Aim: Disease control
Last updated May 09, 2026 05:33 UTC
-
Ultrasound may help doctors predict breathing tube challenges
Diagnosis CompletedThis study looked at whether a neck ultrasound can help doctors predict if placing a breathing tube will be difficult. Researchers observed 246 adult patients who needed general anesthesia with a breathing tube. They measured different parts of the neck using ultrasound and compa…
Sponsor: National Cancer Institute, Egypt • Aim: Diagnosis
Last updated May 08, 2026 12:02 UTC
-
Vitamin b may shield ovarian cancer patients from chemo nerve pain
Symptom relief CompletedThis study looked at whether taking daily vitamin B complex can reduce nerve damage (tingling, numbness, pain) caused by the chemotherapy drug paclitaxel in women with ovarian cancer. 146 adult patients took vitamin B pills every day for 6 months while receiving weekly chemo. Res…
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated May 09, 2026 05:33 UTC
-
Which nerve block wins for cancer surgery pain?
Symptom relief CompletedThis study tested two types of nerve blocks to manage pain after cancer surgery on the upper belly. 70 adults received either an erector spinae plane block or an external oblique intercostal plane block. The goal was to see which one reduces the need for morphine and other pain m…
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC